← All verdicts
Verdict

Deep Overvalued

Every analyzed stock in Deep Overvalued1,218 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Deep Overvalued" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

SPHR
Sphere Entertainment Co.
Deeply overvalued
Communication Services Risk 59 · Elevated
Price$147.40
Model IV$35.64
P/IV3.89
Premium +314% Return to IV: -75.8%
Market implies +31.2%/yr vs model +14.4% · above model
SPPL
SIMPPLE LTD.
Deeply overvalued
Industrials Risk 61 · High
Price$2.16
Model IV$1.20
P/IV2.99
Premium +80% Return to IV: -44.3%
Market implies -3.8%/yr vs model +15.0% · below model
SPRU
SPRUCE POWER HOLDING CORP
Deeply overvalued
Utilities Risk 65 · High
Price$1.64
Model IV$1.77
P/IV1.63
Discount 7% Return to IV: +7.8%
SPRY
ARS Pharmaceuticals, Inc.
Fairly valued
Healthcare Risk 65 · High
Price$4.25
Model IV$3.75
P/IV2.42
Premium +13% Return to IV: -11.8%
Market implies +3.6%/yr vs model +50.0% · below model
SPXC
SPX Technologies, Inc.
Deeply overvalued
Industrials Risk 52 · Elevated
Price$191.82
Model IV$97.27
P/IV2.23
Premium +97% Return to IV: -49.3%
Market implies +20.1%/yr vs model +13.5% · above model
SQFT
Presidio Property Trust, Inc.
Deeply overvalued
Financial Services Risk 59 · Elevated
Price$1.35
Model IV$0.81
P/IV3.43
Premium +67% Return to IV: -40.0%
SQFTP
Presidio Property Trust, Inc.
Deeply overvalued
Financial Services Risk 59 · Elevated
Price$6.60
Model IV$2.57
P/IV2.28
Premium +157% Return to IV: -61.1%
SRBK
SR Bancorp, Inc.
Deeply overvalued
Financial Services Risk 67 · High
Price$19.49
Model IV$12.68
P/IV1.48
Premium +54% Return to IV: -34.9%
SRL
Scully Royalty Ltd.
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$5.57
Model IV$2.71
P/IV2.26
Premium +105% Return to IV: -51.3%
SRTS
Sensus Healthcare, Inc.
Deeply overvalued
Healthcare Risk 53 · Elevated
Price$3.13
Model IV$2.09
P/IV1.48
Premium +50% Return to IV: -33.2%
Market implies +0.8%/yr vs model +2.0% · in line
SSII
SS Innovations International, Inc.
Deeply overvalued
Healthcare Risk 57 · Elevated
Price$3.31
Model IV$0.85
P/IV4.66
Premium +291% Return to IV: -74.4%
Market implies +6.9%/yr vs model +15.0% · below model
SSP
E.W. SCRIPPS Co
Deeply overvalued
Communication Services Risk 69 · High
Price$3.16
Model IV$0.77
P/IV4.43
Premium +313% Return to IV: -75.8%
Market implies +20.3%/yr vs model +3.0% · above model
SSRM
SSR MINING INC.
Deeply overvalued
Financial Services Risk 70 · High
Price$36.24
Model IV$8.76
P/IV3.57
Premium +314% Return to IV: -75.8%
ST
Sensata Technologies Holding plc
Deeply overvalued
Healthcare Risk 63 · High
Price$41.38
Model IV$26.07
P/IV1.96
Premium +59% Return to IV: -37.0%
Market implies +11.2%/yr vs model +5.0% · above model
STEL
Stellar Bancorp, Inc.
Deeply overvalued
Financial Services Risk 60 · High
Price$39.32
Model IV$26.61
P/IV1.40
Premium +48% Return to IV: -32.3%
STFS
Star Fashion Culture Holdings Ltd
Deeply overvalued
Technology Risk 50 · Elevated
Price$3.36
Model IV$2.35
P/IV4.41
Premium +42% Return to IV: -29.8%
Market implies +3.6%/yr vs model +15.0% · below model
STHO
Star Holdings
Deeply overvalued
Real Estate Risk 68 · High
Price$9.32
Model IV$2.26
P/IV3.93
Premium +312% Return to IV: -75.7%
STM
STMicroelectronics N.V.
Deeply overvalued
Technology Risk 58 · Elevated
Price$51.51
Model IV$31.82
P/IV2.18
Premium +62% Return to IV: -38.2%
Market implies +10.2%/yr vs model +3.0% · above model
STOK
Stoke Therapeutics, Inc.
Deeply overvalued
Healthcare Risk 60 · High
Price$29.03
Model IV$9.85
P/IV3.14
Premium +195% Return to IV: -66.1%
Market implies +9.4%/yr vs model +15.0% · below model
STRW
Strawberry Fields REIT, Inc.
Deeply overvalued
Financial Services Risk 60 · High
Price$13.82
Model IV$5.66
P/IV2.32
Premium +144% Return to IV: -59.0%
STSSW
Sharps Technology Inc.
Deeply overvalued
Healthcare Risk 55 · Elevated
Price$0.03
Model IV$0.01
P/IV3.54
Premium +199% Return to IV: -66.6%
Market implies +12.5%/yr vs model +15.0% · in line
STT
STATE STREET CORP
Deeply overvalued
Financial Services Risk 77 · High
Price$193.40
Model IV$98.55
P/IV1.58
Premium +96% Return to IV: -49.0%
SUI
SUN COMMUNITIES INC
Deeply overvalued
Financial Services Risk 75 · High
Price$114.48
Model IV$28.11
P/IV4.40
Premium +307% Return to IV: -75.4%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
Deeply overvalued
Healthcare Risk 63 · High
Price$41.64
Model IV$28.85
P/IV1.60
Premium +44% Return to IV: -30.7%
Market implies +0.5%/yr vs model +5.5% · below model
SVC
Service Properties Trust
Valuation N/A
Financial Services Risk 58 · Elevated
Price$6.67
Model IV
P/IV
Limited data — see page
SW
Smurfit Westrock plc
Deeply overvalued
Basic Materials Risk 58 · Elevated
Price$43.22
Model IV$16.94
P/IV2.43
Premium +155% Return to IV: -60.8%
Market implies +19.8%/yr vs model +8.0% · above model
SWIM
Latham Group, Inc.
Deeply overvalued
Consumer Cyclical Risk 61 · High
Price$6.32
Model IV$2.34
P/IV2.25
Premium +170% Return to IV: -62.9%
Market implies +12.7%/yr vs model -0.1% · above model
SWK
STANLEY BLACK & DECKER, INC.
Deeply overvalued
Industrials Risk 68 · High
Price$88.89
Model IV$31.06
P/IV2.56
Premium +186% Return to IV: -65.1%
Market implies +13.7%/yr vs model -0.2% · above model
SWKS
SKYWORKS SOLUTIONS, INC.
Deeply overvalued
Technology Risk 61 · High
Price$88.35
Model IV$57.30
P/IV1.36
Premium +54% Return to IV: -35.1%
Market implies +7.7%/yr vs model +1.6% · above model
SXT
SENSIENT TECHNOLOGIES CORP
Deeply overvalued
Basic Materials Risk 64 · High
Price$128.60
Model IV$25.41
P/IV4.48
Premium +406% Return to IV: -80.2%
Market implies +25.5%/yr vs model +4.3% · above model
SXTC
China SXT Pharmaceuticals, Inc.
Valuation N/A
Healthcare Risk 33 · Moderate
Price$2.36
Model IV
P/IV
Market implies +20.5%/yr vs model +2.0% · above model
SY
So-Young International Inc.
Deeply overvalued
Technology Risk 54 · Elevated
Price$2.62
Model IV$0.81
P/IV2.41
Premium +224% Return to IV: -69.2%
Market implies +21.0%/yr vs model +2.0% · above model
SYBT
Stock Yards Bancorp, Inc.
Deeply overvalued
Financial Services Risk 73 · High
Price$80.46
Model IV$45.01
P/IV1.59
Premium +79% Return to IV: -44.1%
TAC
TRANSALTA CORP
Deeply overvalued
Utilities Risk 64 · High
Price$12.08
Model IV$5.73
P/IV2.48
Premium +111% Return to IV: -52.6%
TAL
TAL Education Group
Deeply overvalued
Consumer Defensive Risk 56 · Elevated
Price$11.75
Model IV$2.28
P/IV4.26
Premium +416% Return to IV: -80.6%
Market implies +23.1%/yr vs model +2.0% · above model
TATT
TAT TECHNOLOGIES LTD
Deeply overvalued
Industrials Risk 63 · High
Price$38.46
Model IV$18.75
P/IV2.31
Premium +105% Return to IV: -51.3%
Market implies +13.5%/yr vs model +22.9% · below model
TBBK
Bancorp, Inc.
Deeply overvalued
Financial Services Risk 68 · High
Price$50.63
Model IV$27.13
P/IV2.03
Premium +87% Return to IV: -46.4%
TBRG
TruBridge, Inc.
Deeply overvalued
Technology Risk 59 · Elevated
Price$26.24
Model IV$19.15
P/IV1.36
Premium +37% Return to IV: -27.0%
Market implies +9.3%/yr vs model +7.4% · in line
TCBI
TEXAS CAPITAL BANCSHARES INC/TX
Deeply overvalued
Financial Services Risk 67 · High
Price$99.09
Model IV$66.84
P/IV1.49
Premium +48% Return to IV: -32.5%
TCBS
Texas Community Bancshares, Inc.
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$17.38
Model IV$9.18
P/IV1.82
Premium +89% Return to IV: -47.2%
TCBX
Third Coast Bancshares, Inc.
Deeply overvalued
Financial Services Risk 59 · Elevated
Price$45.00
Model IV$25.56
P/IV1.50
Premium +76% Return to IV: -43.2%
TCI
TRANSCONTINENTAL REALTY INVESTORS INC
Deeply overvalued
Financial Services Risk 68 · High
Price$39.10
Model IV$17.07
P/IV2.27
Premium +129% Return to IV: -56.3%
TCPA
TRANSCANADA PIPELINES LTD
Deeply overvalued
Utilities Risk 56 · Elevated
Price$21.90
Model IV$17.27
P/IV1.38
Premium +27% Return to IV: -21.1%
TDAY
USA TODAY Co., Inc.
Deeply overvalued
Communication Services Risk 58 · Elevated
Price$6.36
Model IV$3.97
P/IV1.97
Premium +60% Return to IV: -37.6%
Market implies +2.7%/yr vs model +0.0% · in line
TDC
TERADATA CORP /DE/
Fairly valued
Technology Risk 62 · High
Price$27.84
Model IV$24.51
P/IV1.39
Premium +14% Return to IV: -12.0%
Market implies +7.7%/yr vs model +6.8% · in line
TDG
TransDigm Group INC
Deeply overvalued
Industrials Risk 55 · Elevated
Price$1,140.32
Model IV$840.16
P/IV1.50
Premium +36% Return to IV: -26.3%
Market implies +14.9%/yr vs model +13.3% · in line
TDY
TELEDYNE TECHNOLOGIES INC
Deeply overvalued
Industrials Risk 50 · Elevated
Price$603.79
Model IV$442.24
P/IV1.40
Premium +37% Return to IV: -26.8%
Market implies +11.3%/yr vs model +8.7% · in line
TECH
BIO-TECHNE Corp
Deeply overvalued
Healthcare Risk 53 · Elevated
Price$72.34
Model IV$20.97
P/IV2.46
Premium +245% Return to IV: -71.0%
Market implies +23.8%/yr vs model +7.9% · above model
TEL
TE Connectivity plc
Deeply overvalued
Industrials Risk 58 · Elevated
Price$201.42
Model IV$137.68
P/IV1.55
Premium +46% Return to IV: -31.6%
Market implies +11.4%/yr vs model +7.1% · above model
TENB
Tenable Holdings, Inc.
Deeply overvalued
Technology Risk 60 · High
Price$35.08
Model IV$14.02
P/IV2.01
Premium +150% Return to IV: -60.0%
Market implies +24.4%/yr vs model +15.2% · above model
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Deeply overvalued
Healthcare Risk 53 · Elevated
Price$37.09
Model IV$14.05
P/IV2.51
Premium +164% Return to IV: -62.1%
Market implies +16.9%/yr vs model +4.5% · above model
TFIN
Triumph Financial, Inc.
Deeply overvalued
Financial Services Risk 68 · High
Price$66.07
Model IV$24.78
P/IV2.88
Premium +167% Return to IV: -62.5%
TFPM
Triple Flag Precious Metals Corp.
Deeply overvalued
Financial Services Risk 68 · High
Price$33.78
Model IV$12.18
P/IV2.60
Premium +177% Return to IV: -63.9%
TFSL
TFS Financial CORP
Deeply overvalued
Financial Services Risk 67 · High
Price$17.01
Model IV$5.06
P/IV3.14
Premium +236% Return to IV: -70.3%
TFX
TELEFLEX INC
Deeply overvalued
Healthcare Risk 66 · High
Price$130.30
Model IV$61.35
P/IV2.10
Premium +112% Return to IV: -52.9%
Market implies +8.1%/yr vs model +2.0% · above model
TG
TREDEGAR CORP
Deeply overvalued
Basic Materials Risk 56 · Elevated
Price$7.16
Model IV$2.91
P/IV2.69
Premium +146% Return to IV: -59.4%
Market implies +14.9%/yr vs model +5.0% · above model
TGLS
Tecnoglass Inc.
Deeply overvalued
Industrials Risk 59 · Elevated
Price$38.32
Model IV$31.32
P/IV1.38
Premium +22% Return to IV: -18.3%
Market implies +14.3%/yr vs model +15.4% · in line
TGS
GAS TRANSPORTER OF THE SOUTH INC
Deeply overvalued
Utilities Risk 66 · High
Price$29.66
Model IV$14.97
P/IV2.08
Premium +98% Return to IV: -49.5%
TH
Target Hospitality Corp.
Deeply overvalued
Consumer Cyclical Risk 53 · Elevated
Price$19.25
Model IV$11.83
P/IV1.47
Premium +63% Return to IV: -38.5%
Market implies +11.2%/yr vs model +6.9% · above model
THR
Thermon Group Holdings, Inc.
Deeply overvalued
Technology Risk 60 · High
Price$61.14
Model IV$13.37
P/IV4.57
Premium +357% Return to IV: -78.1%
Market implies +31.5%/yr vs model +11.7% · above model